The Jersey City Medical Center unveiled their new Neuro Interventional Cath Lab yesterday, which will help enhance the diagnosis and treatment of strokes.
By John Heinis/Hudson County View
“Patients and their families can be confident that they will receive the best available, latest technology from a multidisciplinary group of neurospecialists performing endovascular neurosurgical interventions at Jersey City Medical Center,” JCMC Interim Director of Endovascular Neurosurgery Dr. Anil Nair said in a statement.
“Our pursuit of innovation and the most current, best practices represents our commitment to deliver the best possible outcomes for our patients.”
With this addition, the medical center will be the only facility in Hudson County providing full time open and endovascular neurosurgical care of complex neurovascular pathology.
Additionally, the JCMC will now be able to perform minimally invasive procedures on the new system to treat a wide range of clinical problems including stroke, carotid artery disease, cerebral aneurysms, and AVMs.
According to the American Stroke Association, someone in the U.S. suffers a stroke every 40 seconds, and stroke is a leading cause of serious long-term disability among Americans.
“The Neuro Interventional Cath Lab will significantly enhance our ability to diagnose and treat complex neurovascular diseases such as aneurysms and arteriovenous malformations, providing our patients with the most advanced care and improved outcomes,” JCMC President and CEO Michael Prilutsky added.
The catheter-based procedures are designed to reduce some of the risks and recovery time found in traditional surgical approaches.
Among the many benefits of catheter-based interventions are shorter hospital stays, reduced recovery time without the pain of a large incision, and most importantly, avoiding trauma to the brain and spine seen in traditional surgery while providing effective treatment.